World's 1st iPS Therapy for Spinal Cord Injuries Starts in Japan
Tokyo, Jan.
Japan Team Makes iPS Cells with Low Rejection Risk
Kyoto, March 8 (Jiji Press)--A Japanese team has said it succeeded in producing induced pluripotent stem, or iPS, cells with low rejection risk by using the technology of genome editing.
Japan Govt OKs Transplants of iPS-Made Corneal Cells
Tokyo, March 5 (Jiji Press)--A team of Osaka University researchers received approval in principle on Tuesday from a Japanese health ministry panel for the world's first clinical study plan to
Japanese Develop Low-Price iPS Cell Culture Fluid
Tokyo, Feb. 5 (Jiji Press)--Keio University's School of Medicine and Ajinomoto Co.
